Drug Trial Radar · NCT06752850
A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis
Last checked: Nov 20, 2026Latest source record: Apr 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
37
Actual
Start
Dec 19, 2024
Primary completion
Nov 17, 2026
Study completion Dec 28, 2026
Sponsor
- Lead sponsor
- Swedish Orphan BiovitrumIndustry
- Sponsor type
- Industry
- Collaborators
- PSI CRO
- First posted
- Dec 31, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The rationale for conducting this open-label phase 4 study is to assess whether once-weekly prophylaxis with efanesoctocog alfa (50 IU/kg) improves the disease course of existing synovial hypertrophy and prevents the risk of joint bleeds in patients with moderate or severe haemophilia A. The use of imaging assessments will allow for objective detection and monitoring of synovial hypertrophy, and thus expand on the previous findings demonstrating positive effects of once-weekly prophylaxis with efanesoctocog alfa (50 IU/kg) on joint health.
Conditions
- Haemophilia A (Moderate or Severe)
- Hemophilia, Classic
- Haemophilia
- Hemophilia
- Classic Hemophilia
- Synovial Hypertrophy
Interventions
Efanesoctocog alfaDrug
50 IU/kg once weekly, Intravenous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) synovial hypertrophy domain score decrease.Time frame: Baseline to 12 months
Locations
10 sites in 4 countries. Site status is shown where the registry gives one.
Sobi Investigational Site
Milan, Italy
Sobi Investigational Site
Naples, Italy
Sobi Investigational Site
Rozzano, Italy
Sobi Investigational Site
Oslo, Norway
Sobi Investigational Site
Barcelona, Spain
Sobi Investigational Site
Madrid, Spain
Sobi Investigational Site
Seville, Spain
Sobi Investigational Site
Valencia, Spain
Sobi Investigational Site
Gothenburg, Sweden
Sobi Investigational Site
Malmö, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.